14  Clinical Trials in CHIP and CCUS

14.1 Endpoints in CHIP trials

  • VTE could be considered in the composite outcome for any potential CHIP treatment trial with a cardiovascular focus.

15 EVITA trial

  • Oral vitamin C in CCUS and LR-MDS

16 PIMM Study: Ivosidenib in IDH1m CCUS

  • 81% response rate

17 IMPACT: Canakinumab in CCUS

18 NLRP3i (Colchicine) in CVD outcomes